FDA Week - 04/12/2019

Gottlieb’s Final Actions At FDA Lay Out To-Do List For Sharpless, Agency

April 08, 2019
Since his early March announcement that he would be leaving FDA , former agency commissioner Scott Gottlieb ramped up work to wrap up, or initiate, myriad goals he wanted to accomplish during his time with the agency. The barrage of announcements, guidances, rules and enforcement actions essentially leaves a public to-do list for acting commissioner Ned Sharpless, who heads over to FDA from the National Cancer Institute, and for whomever is confirmed to permanently succeed Gottlieb. Gottlieb issued a spate...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.